Larkspur Biosciences
Morgan Welzel O'Shea is a skilled medicinal chemist with extensive experience in the pharmaceutical industry. Currently serving as a Medicinal Chemist at Larkspur Biosciences since May 2022, Morgan previously held the position of Senior Research Scientist I at C4 Therapeutics, Inc., following a progression from Research Scientist II. Prior to this, Morgan contributed to H3 Biomedicine as an Investigator in Medicinal Chemistry and held various roles, including Senior Research Associate, from August 2011 to November 2018. Earlier experience includes a Research Associate III position at the Broad Institute and an internship in Medicinal Chemistry at Boehringer Ingelheim. Morgan earned a M.Sc. in Organic Chemistry from Boston University between 2007 and 2009.
This person is not in any teams
Larkspur Biosciences
Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.